Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.

Huyen MN, Cobelens FG, Buu TN, Lan NT, Dung NH, Kremer K, Tiemersma EW, van Soolingen D.

Antimicrob Agents Chemother 2013;57(8):3620-7.

Abstract http://www.ncbi.nlm.nih.gov/pubmed/23689727

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us